Systems and methods for accumulation
    33.
    发明授权
    Systems and methods for accumulation 有权
    积累的系统和方法

    公开(公告)号:US09242751B1

    公开(公告)日:2016-01-26

    申请号:US13412033

    申请日:2012-03-05

    Abstract: Method and systems for accumulation are described. In one embodiment, a dispensing station includes a receiving opening, a dispensing opening and a storage area. The dispensing station receives and dispenses a container. A transportable storage system includes multiple partitions disposed on a carrier portion to define multiple carriage sections. The carriage sections are electronically identifiable and selectively hold or eject the container. A bin apparatus for receiving the container includes a movable portion to selectively hold and release the container. A control unit for commanding the bin apparatus to dispense the container to a desired carriage section of the transportable storage system is provided. Additional methods and systems are disclosed.

    Abstract translation: 描述积累的方法和系统。 在一个实施例中,分配站包括接收开口,分配开口和存储区域。 分配站接收并分配容器。 可移动存储系统包括设置在载体部分上以限定多个托架部分的多个分隔件。 托架部分是电子可识别的并且选择性地保持或弹出容器。 用于容纳容器的收纳箱装置包括用于选择性地保持和释放该容器的可移动部分。 提供了一种控制单元,用于命令箱装置将容器分配到可移动存储系统的期望的托架部分。 公开了附加的方法和系统。

    Systems and methods for sorting
    34.
    发明授权
    Systems and methods for sorting 有权
    排序系统和方法

    公开(公告)号:US08977386B1

    公开(公告)日:2015-03-10

    申请号:US14526787

    申请日:2014-10-29

    Abstract: Method and systems for sorting are described. In one embodiment, a container is released into a pocket section, with the pocket section being at a first alignment stage. The pocket section is rotated with the container away from the first alignment stage to a second alignment stage. Attributes of the container are acquired at the second alignment stage. An order to which the container belongs is identified with the acquired attributes. The pocket section with the container is rotated to a third alignment stage. The location of the third alignment stage is selected based on the identified order. The container is received to group with one or more containers in the identified order. Additional methods and systems are disclosed.

    Abstract translation: 描述用于排序的方法和系统。 在一个实施例中,容器被释放到袋部分中,其中袋部分处于第一对准阶段。 口袋部分随着容器旋转离开第一对准台到第二对准台。 在第二对准阶段获取容器的属性。 容器所属的订单用所获取的属性标识。 具有容器的口袋部分旋转到第三对准阶段。 基于所识别的顺序选择第三对准阶段的位置。 接收容器以按照确定的顺序与一个或多个容器分组。 公开了附加的方法和系统。

    Methods and systems for drug purchase validation
    35.
    发明授权
    Methods and systems for drug purchase validation 有权
    药物购买验证的方法和系统

    公开(公告)号:US08738399B1

    公开(公告)日:2014-05-27

    申请号:US13340809

    申请日:2011-12-30

    CPC classification number: G06F19/328 G06F19/00 G06F19/3456 G06Q50/22

    Abstract: In an example embodiment, drug sale data is accessed from a prescription drug wholesaler regarding prescription drugs sold to the pharmacy by the prescription drug wholesaler during a period of time. Pharmacy claims data over the period of time is accessed, where the pharmacy claims data reflects a plurality of claims that were submitted for adjudication by the pharmacy during the period of time. A number of units of a prescription drug associated with the plurality of claims submitted during the period of time by the pharmacy for adjudication are determined based on the pharmacy claims data. This number of units of the prescription drug is compared with the number of units of the prescription drug sold to the pharmacy. A determination is then made as to whether a discrepancy exists based on the results of the comparison. Additional methods and systems are disclosed.

    Abstract translation: 在一个示例性实施例中,药物销售数据从处方药批发商处获得,处方药在一段时间内由处方药批发商销售给药店。 药房索赔数据在一段时间内被访问,药房索赔数据反映了药房在一段时间内提交给裁决的多项索赔。 根据药房索赔数据确定了药房审判期间在一段时间内提交的与多个索赔相关的许多处方药单位。 将处方药单位数量与销往药房的处方药单位数进行比较。 然后根据比较结果确定是否存在差异。 公开了附加的方法和系统。

    Methods and systems for pharmacy location
    36.
    发明授权
    Methods and systems for pharmacy location 有权
    药房定位方法和系统

    公开(公告)号:US08706522B2

    公开(公告)日:2014-04-22

    申请号:US13221643

    申请日:2011-08-30

    CPC classification number: G06Q50/22 G06F19/00 G06Q30/02 G06Q30/06 G06Q30/0639

    Abstract: Methods and systems for pharmacy location are described. In one embodiment, a plurality of pharmacy network associations of a member is determined. The pharmacy network associations are associated with a drug benefit plan of the member. A pharmacy within a pharmacy network association of the plurality of pharmacy network associations is capable of fulfilling a prescription for a prescription drug. A location associated with the member is accessed. A display is generated based on the determination of the pharmacy network associations and the location of the member. The display includes a first indicator and a second indicator. A first network pharmacy of a first pharmacy network association is associated with the first indicator on the display. A second network pharmacy of a second pharmacy network association is associated with the second indicator on the display. Additional methods and systems are disclosed.

    Abstract translation: 描述了药房位置的方法和系统。 在一个实施例中,确定成员的多个药店网络关联。 药房网络协会与会员的药物福利计划相关联。 多个药学网络协会的药学网络协会内的药房能够满足处方药的处方。 访问与该成员关联的位置。 基于药剂网络关联的确定和成员的位置生成显示。 显示器包括第一指示器和第二指示器。 第一药房网络关联的第一网络药房与显示器上的第一指示符相关联。 第二药房网络关联的第二网络药房与显示器上的第二指示符相关联。 公开了附加的方法和系统。

    Methods and systems for improving therapy adherence
    37.
    发明授权
    Methods and systems for improving therapy adherence 有权
    改善治疗依从性的方法和系统

    公开(公告)号:US08666926B1

    公开(公告)日:2014-03-04

    申请号:US13066664

    申请日:2011-04-19

    CPC classification number: G06N5/022 G06F19/00 G06F19/3456 G06N5/02

    Abstract: A system and method for improving adherence to therapy programs, in particular to adherence to medication therapy and/or to healthcare therapy, that includes medication therapy. Methods of the present invention may also be used to improve compliance with and/or adherence to other wellness and/or health care programs. Methods and systems of the invention may include methods of identifying patients who are at risk of non-adherence, non-compliance, or likelihood of cessation with a therapy program, predicting a basis for such noncompliance, and targeting interventions directed to patients who have been identified as likely to be non-compliant, wherein interventions take into consideration the predicted basis for noncompliance.

    Abstract translation: 一种用于改善对治疗程序的依从性的系统和方法,特别是对药物治疗和/或医疗保健治疗的依从性,其包括药物治疗。 本发明的方法也可用于改善对其他健康和/或保健程序的依从性和/或遵守。 本发明的方法和系统可以包括识别患有不遵守,不遵守或有可能停止治疗方案的患者的方法,预测这种不合规的基础,并针对已经被 被确定为可能不合规,其中干预措施考虑到不合规性的预测依据。

    METHODS AND SYSTEMS FOR FULFILLING DRUG ORDERS
    38.
    发明申请
    METHODS AND SYSTEMS FOR FULFILLING DRUG ORDERS 审中-公开
    用于制造药物的方法和系统

    公开(公告)号:US20130173277A1

    公开(公告)日:2013-07-04

    申请号:US13340318

    申请日:2011-12-29

    CPC classification number: G06Q50/22 G06F19/00 G06F19/3456 G06Q10/10

    Abstract: Methods and systems for fulfillment gateway are described. In one embodiment, a prescription order for a prescription drug is received from an order processing station. An order message associated with the prescription order is generated. The order message has a prescription parameter and a dispensation preference for fulfilling the prescription order. The order message is assigned to an order fulfillment station based on the prescription parameter, the dispensation preference and a dispensary attribute of the order fulfillment station. In other embodiments, the order message is selected for delivery based on based on the prescription parameter, the dispensation preference and a dispensary attribute of the order fulfillment station. Additional methods and systems are disclosed.

    Abstract translation: 描述了实现网关的方法和系统。 在一个实施方案中,从订单处理站接收处方药的处方顺序。 生成与处方订单相关联的订单消息。 订单信息具有处方参数和分配偏好以满足处方订单。 订单消息根据订单执行站的处方参数,分配偏好和药房属性分配给订单执行站。 在其他实施例中,基于订单执行站的处方参数,分配偏好和药剂处理属性来选择订单消息用于递送。 公开了附加的方法和系统。

    METHODS AND SYSTEMS FOR TREATMENT REGIMEN MANAGEMENT
    39.
    发明申请
    METHODS AND SYSTEMS FOR TREATMENT REGIMEN MANAGEMENT 有权
    治疗方案和系统管理

    公开(公告)号:US20130085767A1

    公开(公告)日:2013-04-04

    申请号:US13251617

    申请日:2011-10-03

    CPC classification number: G06F19/3481 G06F19/00 G06F19/3456 G06Q50/22

    Abstract: Methods and systems for treatment regimen management are described. In one embodiment, a treatment regimen associated with a user is determined. The treatment regimen includes treatment first treatment component and a second treatment component. The treatment regimen also includes a first treatment schedule associated with the first treatment component and a second treatment schedule associated with the second treatment component. Multiple treatment events are scheduled in an electronic calendar. The treatment events are based upon the first treatment schedule and the second treatment schedule. A treatment alert associated with each of the treatment events is generated. Other methods and systems are also described.

    Abstract translation: 描述了治疗方案管理的方法和系统。 在一个实施例中,确定与用户相关联的治疗方案。 治疗方案包括治疗第一治疗组分和第二治疗组分。 治疗方案还包括与第一治疗组分相关的第一治疗方案和与第二治疗组分相关的第二治疗方案。 多个治疗事件安排在电子日历中。 治疗事件基于第一次治疗计划和第二次治疗计划。 产生与每个治疗事件相关联的治疗警报。 还描述了其它方法和系统。

    Identification of specialty drugs
    40.
    发明申请
    Identification of specialty drugs 有权
    鉴定特种药物

    公开(公告)号:US20090192807A1

    公开(公告)日:2009-07-30

    申请号:US12011621

    申请日:2008-01-28

    CPC classification number: G06Q50/22 G06F19/00 G06Q10/087 G06Q30/0278 G06Q50/24

    Abstract: Methods for determining whether a drug is a specialty drug, methods for creating tools to be used in making the determination, and the tools themselves are disclosed. The overall value of a drug depends on the drug's attribute values with respect to each of a set of drug attributes (concerning, e.g., the drug's route of administration, targeted disease, possible adverse reactions, risk of toxicity, cost, need for patient compliance with the treatment regime, and handling, preparation, and/or storage requirements. If the overall value or its partial overall values meet certain criteria, the drug is deemed to be a specialty drug.

    Abstract translation: 公开了用于确定药物是特殊药物的方法,用于制备用于确定的工具的方法和工具本身。 药物的总体价值取决于药物的属性值,关于一组药物属性(关于例如药物的给药途径,靶向疾病,可能的不良反应,毒性风险,成本,患者依从性的需要) 治疗方案,处理,准备和/或储存要求,如果总体价值或部分总体价值符合某些标准,该药物被视为特种药物。

Patent Agency Ranking